Zusammenfassung
Nur wenige Komplikationen in der Herzchirurgie haben einen vergleichbar negativen Einfluss auf die Prognose des Patienten wie perioperative Nierenfunktionsstörungen, die heute unter der Abkürzung CSA-AKI („cardiac surgery-associated acute kidney injury“) zusammengefasst werden: bereits geringfügige Veränderungen des postoperativen Plasmakreatinins sind mit einer relevanten Prognoseverschlechterung assoziiert.
Die vorliegende Arbeit stellt eine aktualisierte und erweiterte Zusammenfassung kürzlich publizierter Konsensus-Statements der Acute Dialysis Quality Initiative (ADQI) zum Themenkomplex CSA-AKI dar und gibt einen Überblick über die Epidemiologie dieser Komplikation, die nach gegenwärtigem Verständnis beteiligten pathophysiologischen Mechanismen, prophylaktische Maßnahmen und therapeutische Ansätze.
Während zum gegenwärtigen Zeitpunkt kein pharmakologischer Ansatz bekannt ist, der sich in großen prospektiven Studien als effizient erwiesen hätte, eine postoperative Nierenfunktionsstörung zu vermeiden, zeigt die Zusammenstellung der pathophysiologischen Mechanismen deutlich, dass zahlreiche derjenigen Faktoren, die zu einer perioperativen Nierenfunktionsstörung beitragen, unter Einbindung aller beteiligten Fachdisziplinen durchaus klinisch modifizierbar und im Sinne guter klinischer Praxis mit den Zielen: Vermeidung endogener und exogener Noxen, Normoglykämie, Aufrechterhaltung einer adäquaten systemischen Perfusion, Euvolämie und eines, dem individuellen Verbrauch angemessenen Sauerstoffangebots sowie Vermeidung embolischer Komplikationen positiv beeinflusst werden können. Im Umkehrschluss kann CSA-AKI – zumindest partiell – auch als Ausdruck eines suboptimalen klinischen Managements betrachtet werden, welches klinikindividuell und interdisziplinär in Angriff genommen werden sollte.
Die Therapiekonzepte, die zur Behandlung des etablierten CSA-AKI zum Einsatz kommen, unterscheiden sich nicht grundlegend von den Vorgehensweisen, die bei Patienten mit Nierenfunktionsstörungen anderer Ätiologie angewendet werden. Allerdings scheint bei herzchirurgischen Patienten die frühzeitige Initiierung einer Nierenersatztherapie – bevor urämische Komplikationen auftreten – mit einer günstigeren Prognose verknüpft zu sein. Die Gabe von Schleifendiuretika hat keinen positiven Einfluss auf den Verlauf des CSA-AKI. Auch die Gabe von Dopamin in „Nierendosis“ ist nicht geeignet, eine Nierenfunktionsstörung zu verhindern oder sinnvoll zu behandeln.
Abstract
Few complications in cardiac surgery have such a negative impact on patient prognosis as perioperative renal dysfunction, now called cardiac surgery-associated acute kidney injury (CSA-AKI): even the slightest increases in postoperative plasma creatinine are associated with a relevant worsening of prognosis.
The present manuscript is an updated and extended summary of the recently published consensus statement of the Acute Dialysis Quality Initiative (ADQI) on CSA-AKI intended to give an overview of the epidemiological and pathophysiological mechanisms of this complication and interventions aimed to prevent and treat it.
At present, no pharmacological approach has been shown to be effective in large scale prospective randomized trials to prevent CSA-AKI. In contrast, the pathophysiological mechanisms behind this complication are highly suggestive that many of the factors associated with CSA-AKI may be modified into a positive direction by implementing an interdisciplinary approach with the clinical goals: prevention of endogeneous and exogeneous nephrotoxins, maintenance of normoglycemia, adequate systemic perfusion pressure and flow, and euvolemia, adjusting systemic oxygen delivery to demand, and by avoidance of embolic complications. Thus, CSA-AKI may – at least in part – be reflective of a suboptimal clinical management that can be optimized according to the individual center.
The therapy of established CSA-AKI does not differ from treatment of acute renal failure of other etiology. However, published data suggest that the early institution of renal replacement therapy, i.e., before uremic complications have occurred, may be associated with an improved prognosis. The use of loop diuretics is not beneficial and may be even harmful, and renal dose dopamine does not prevent CSA-AKI or constitute a reasonable treatment of this complication.
Literatur
Bellomo R, Auriemma S, Fabbri A et al (2008) The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 31:166–178
Schetz M, Bove T, Morelli A et al (2008) Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs 31:179–189
Tolwani A, Paganini E, Joannidis M et al (2008) Treatment of patients with cardiac surgery associated-acute kidney injury. Int J Artif Organs 31:190–196
Hoste EA, Cruz DN, Davenport A et al (2008) The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs 31:158–165
Ronco C, Kellum JA, Bellomo R (2008) Cardiac surgery-associated acute kidney injury. Int J Artif Organs 31:156–157
Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
Mangano CM, Diamondstone LS, Ramsay JG et al (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194–203
Bundesgeschäftsstelle für Qualitätssicherung (BQS-online.org) Ergebnisse der Qualitätssicherung Herzchirurgie
Heringlake M, Knappe M, Vargas-Hein O et al (2006) Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol 72:645–654
Lassnigg A, Schmidlin D, Mouhieddine M et al (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597–1605
Lassnigg A, Schmid ER, Hiesmayr M et al (2008) Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 36:1129–1137
Stafford-Smith M, Patel UD, Phillips-Bute BG et al (2008) Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis 15:257–277
Wijeysundera DN, Karkouti K, Beattie WS et al (2006) Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104:65–72
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41
Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470
Brosius FC 3rd, Hostetter TH, Kelepouris E et al (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114:1083–1087
Huerta-Alardin AL, Varon J, Marik PE (2005) Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians. Crit Care 9:158–169
Holt S, Moore K (2000) Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol 8:72–76
Moore KP, Holt SG, Patel RP et al (1998) A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 273:31731–31737
Miller CC 3rd, Villa MA, Achouh P et al (2008) Intraoperative skeletal muscle ischemia contributes to risk of renal dysfunction following thoracoabdominal aortic repair. Eur J Cardiothorac Surg 33:691–694
Miller CC 3rd, Villa MA, Sutton J et al (2009) Serum myoglobin and renal morbidity and mortality following thoracic and thoraco-abdominal aortic repair: does rhabdomyolysis play a role? Eur J Vasc Endovasc Surg 37:388–394
De Freitas Carvalho DA, Valezi AC, De Brito EM et al (2006) Rhabdomyolysis after bariatric surgery. Obes Surg 16:740–744
Wigfield CH, Lindsey JD, Munoz A et al (2006) Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI >or=40. Eur J Cardiothorac Surg 29:434–440
Hofmann D, Buettner M, Rissner F et al (2007) Prognostic value of serum myoglobin in patients after cardiac surgery. J Anesth 21:304–310
Vercaemst L (2008) Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol 40:257–267
Haase M, Haase-Fielitz A, Bagshaw SM et al (2007) Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? Contrib Nephrol 156:340–353
Haase M, Haase-Fielitz A, Bellomo R et al (2009) Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 37:39–47
Pannu N, Nadim MK (2008) An overview of drug-induced acute kidney injury. Crit Care Med 36:S216–S223
Benedetto U, Sciarretta S, Roscitano A et al (2008) Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg 86:1160–1165
Arora P, Rajagopalam S, Ranjan R et al (2008) Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 3:1266–1273
Ryckwaert F, Colson P, Ribstein J et al (2001) Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 86:169–175
Wagner F, Yeter R, Bisson S et al (2003) Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med 31:1421–1428
Ranucci M, Ballotta A, Kunkl A et al (2008) Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol 101:1112–1118
Mockel M, Radovic M, Kuhnle Y et al (2008) Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 23:1588–1594
Heyman SN, Rosenberger C, Rosen S (2005) Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 20(Suppl 1):i6–i11
Dangas G, Lakovou L, Nikolsky E et al (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13–19
Nikolsky E, Mehran R, Lasic Z et al (2005) Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67:706–713
Carson JL, Scholz PM, Chen AY et al (2002) Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40:418–423
Doddakula K, Al-Sarraf N, Gately K et al (2007) Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc Thorac Surg 6:314–318
Halkos ME, Puskas JD, Lattouf OM et al (2008) Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 136:631–640
Ouattara A, Lecomte P, Le Manach Y et al (2005) Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103:687–694
Doenst T, Wijeysundera D, Karkouti K et al (2005) Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 130:1144
Ascione R, Rogers CA, Rajakaruna C et al (2008) Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 118:113–123
Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067–2072
Ranucci M, De Toffol B, Isgro G et al (2006) Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care 10:R167
Heringlake M, Wernerus M, Grunefeld J et al (2007) The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care 11:R51
Van Den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
Griesdale DE, De Souza RJ, Van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:821–827
Lecomte P, Van Vlem B, Coddens J et al (2008) Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care 12:R154
Gandhi GY, Nuttall GA, Abel MD et al (2007) Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146:233–243
Lipshutz AK, Gropper MA (2009) Perioperative glycemic control: an evidence-based review. Anesthesiology 110:408–421
Lecomte P, Foubert L, Nobels F et al (2008) Dynamic tight glycemic control during and after cardiac surgery is effective, feasible and safe. Anesth Analg 107:51–58
Legrand M, Mik EG, Johannes T et al (2008) Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 14:502–516
Abuelo JG (2007) Normotensive ischemic acute renal failure. N Engl J Med 357:797–805
Urzua J, Troncoso S, Bugedo G et al (1992) Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 6:299–303
Fischer UM, Weissenberger WK, Warters RD et al (2002) Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 17:401–406
Shanmugam G (2005) Vasoplegic syndrome-the role of methylene blue. Eur J Cardiothorac Surg 28:705–710
Hobbhahn J, Habazettl H, Conzen P et al (1991) Complications caused by protamine. 1: Pharmacology and pathophysiology. Anaesthesist 40:365–374
Hobbhahn J, Habazettl H, Conzen P et al (1991) Complications caused by protamine. 2. Therapy and prevention. Anaesthesist 40:421–428
Brienza N, Giglio MT, Marucci M et al (2009) Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 37:2079–2090
Kaczmarczyk G, Vogel S, Krebs M et al (1996) Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs. Am J Physiol 271:R1396–R1402
Boldt J, Brenner T, Lehmann A et al (2003) Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 75:906–912
Ranucci M, Romitti F, Isgro G et al (2005) Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg 80:2213–2220
Valentine S, Barrowcliffe M, Peacock J (1993) A comparison of effects of fixed and tailored cardiopulmonary bypass flowrates on renal function. Anaesth Intensive Care 21:304–308
Fiore G, Brienza N, Cicala P et al (2006) Superior mesenteric artery blood flow modifications during off-pump coronary surgery. Ann Thorac Surg 82:62–67
Blauth CI, Cosgrove DM, Webb BW et al (1992) Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 103:1104–1111; discussion 1111–1112
Davila-Roman VG, Kouchoukos NT, Schechtman KB et al (1999) Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117:111–116
Charytan DM, Marulkar S (2006) Relationship of aortic atherosclerosis to acute renal failure following cardiac surgery. J Nephrol 19:628–633
Scolari F, Ravani P, Pola A et al (2003) Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 14:1584–1590
Scolari F, Tardanico R, Zani R et al (2000) Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 36:1089–1109
Van Zaane B, Zuithoff NP, Reitsma JB et al (2008) Meta-analysis of the diagnostic accuracy of transesophageal echocardiography for assessment of atherosclerosis in the ascending aorta in patients undergoing cardiac surgery. Acta Anaesthesiol Scand 52:1179–1187
Shann KG, Likosky DS, Murkin JM et al (2006) An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution and the inflammatory response. J Thorac Cardiovasc Surg 132:283–290
Svenarud P, Persson M, Van Der Linden J (2004) Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial. Circulation 109:1127–1132
Reston JT, Tregear SJ, Turkelson CM (2003) Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 76:1510–1515
Cheng DC, Bainbridge D, Martin JE et al (2005) Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 102:188–203
Panesar SS, Athanasiou T, Nair S et al (2006) Early outcomes in the elderly: a meta-analysis of 4921 patients undergoing coronary artery bypass grafting-comparison between off-pump and on-pump techniques. Heart 92:1808–1816
Wagener G, Gubitosa G, Wang S et al (2009) A comparison of urinary neutrophil gelatinase-associated lipocalin in patients undergoing on- versus off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23:195–199
Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17:1503–1520
Nigwekar SU, Kandula P (2009) N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg 87:139–147
Ho KM, Morgan DJ (2009) Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. Am J Kidney Dis 53:33–40
Naughton F, Wijeysundera D, Karkouti K et al (2008) N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 55:827–835
Tanaka K, Weihrauch D, Kehl F et al (2002) Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 97:1485–1490
Wijeysundera DN, Karkouti K, Rao V et al (2009) N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 37:1929–1934
Landoni G, Biondi-Zoccai GG, Zangrillo A et al (2007) Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21:502–511
Lee HT, Kim M, Kim N et al (2007) Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 293:F713–F722
Lee HT, Ota-Setlik A, Fu Y et al (2004) Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101:1313–1324
Julier K, Da Silva R, Garcia C et al (2003) Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98:1315–1327
Heringlake M (2002) Cardio-renal-axis-physiology, pathophysiology and clinical relevance? Anasthesiol Intensivmed Notfallmed Schmerzther 37:250–257
Riddez L, Hahn RG, Brismar B et al (1997) Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 25:635–640
Hynynen M, Salmenpera M, Harjula AI et al (1990) Atrial pressure and hormonal and renal responses to acute cardiac tamponade. Ann Thorac Surg 49:632–637
Clerico A, Recchia FA, Passino C et al (2006) Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 290:H17–H29
McGuinness J, Bouchier-Hayes D, Redmond JM (2008) Understanding the inflammatory response to cardiac surgery. Surgeon 6:162–171
McBride WT (2007) Mediators of inflammation at cardiac surgery. Appl Cardiopulm Pathophysiol 11:4–22
Heymans S, Hirsch E, Anker SD et al (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:119–129
Deng MC, Dasch B, Erren M et al (1996) Impact of left ventricular dysfunction on cytokines, hemodynamics and outcome in bypass grafting. Ann Thorac Surg 62:184–190
Baker RC, Armstrong MA, Allen SJ et al (2002) Role of the kidney in perioperative inflammatory responses. Br J Anaesth 88:330–334
Tripepi G, Mallamaci F, Zoccali C (2005) Inflammation markers, adhesion molecules and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16(Suppl 1):S83–S88
Wan L, Bagshaw SM, Langenberg C et al (2008) Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36:S198–S203
Wang W, Zolty E, Falk S et al (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291:F1090–F1095
Liakopoulos OJ, Choi YH, Haldenwang PL et al (2008) Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 29:1548–1559
Huffmyer JL, Mauermann WJ, Thiele RH et al (2009) Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23:468–473
Fedoruk LM, Wang H, Conaway MR et al (2008) Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg 85:1521–1525
Tang AT, Alexiou C, Hsu J et al (2002) Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg 74:372–377
Boldt J, Brosch C, Lehmann A et al (2004) The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 99:1009–1017
Boldt J, Brosch C, Piper SN et al (2001) Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29:952–958
Sandek A, Rauchhaus M, Anker SD et al (2008) The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care 11:632–639
Geppert A, Huber K (2004) Inflammation and cardiovascular diseases: lessons that can be learned for the patient with cardiogenic shock in the intensive care unit. Curr Opin Crit Care 10:347–353
Geppert A, Dorninger A, Delle-Karth G et al (2006) Plasma concentrations of interleukin-6, organ failure, vasopressor support and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 34:2035–2042
Lenz A, Franklin GA, Cheadle WG (2007) Systemic inflammation after trauma. Injury 38:1336–1345
Kinugawa T, Kato M, Ogino K et al (2003) Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. Int J Cardiol 87:83–90
Matsuoka T (1990) A sedative effect of dopamine on the respiratory burst in neonatal polymorphonuclear leukocytes. Pediatr Res 28:24–27
Sookhai S, Wang JH, Winter D et al (2000) Dopamine attenuates the chemoattractant effect of interleukin-8: a novel role in the systemic inflammatory response syndrome. Shock 14:295–299
Boldt J, Brosch C, Suttner S et al (2002) Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation and markers of organ function. Intensive Care Med 28:1462–1469
Fabre O, Vincentelli A, Corseaux D et al (2008) Comparison of blood activation in the wound, active vent and cardiopulmonary bypass circuit. Ann Thorac Surg 86:537–541
Marcheix B, Carrier M, Martel C et al (2008) Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg 85:530–535
Carl M, Alms A, Braun J et al (2007) Guidelines for intensive care in cardiac surgery patients: haemodynamic monitoring and cardio-circulatory treatment guidelines of the German Society for Thoracic and Cardiovascular Surgery and the German Society of Anaesthesiology and Intensive Care Medicine. Thorac Cardiovasc Surg 55:130–148
Sumeray M, Robertson C, Lapsley M et al (2001) Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery. J Nephrol 14:397–402
Yavuz S, Ayabakan N, Goncu MT et al (2002) Effect of combined dopamine and diltiazem on renal function after cardiac surgery. Med Sci Monit 8:PI45–PI50
Woo EB, Tang AT, El-Gamel A et al (2002) Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 22:106–111
Myles PS, Buckland MR, Schenk NJ et al (1993) Effect of „renal-dose“ dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21:56–61
Friedrich JO, Adhikari N, Herridge MS et al (2005) Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142:510–524
Ranucci M, Soro G, Barzaghi N et al (2004) Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78:1332–1337
Caimmi PP, Pagani L, Micalizzi E et al (2003) Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17:491–494
Cogliati AA, Vellutini R, Nardini A et al (2007) Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 21:847–850
Bove T, Landoni G, Calabro MG et al (2005) Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 111:3230–3235
Landoni G, Biondi-Zoccai GG, Marino G et al (2008) Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 22:27–33
Lassnigg A, Donner E, Grubhofer G et al (2000) Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11:97–104
Lombardi R, Ferreiro A, Servetto C (2003) Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail 25:775–786
Mahesh B, Yim B, Robson D et al (2008) Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg 33:370–376
Sezai A, Shiono M, Orime Y et al (2000) Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 69:732–738
Hummel M, Kuhn M, Bub A et al (1992) Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients. Clin Invest 70:674–682
Hummel M, Kuhn M, Bub A et al (1993) Urodilatin, a new therapy to prevent kidney failure after heart transplantation. J Heart Lung Transplant 12:209–217
Mentzer RM Jr, Oz MC, Sladen RN et al (2007) Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol 49:716–726
Chen HH, Sundt TM, Cook DJ et al (2007) Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation 116:I134–I138
Aaronson KD, Sackner-Bernstein J (2006) Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA 296:1465–1466
Sackner-Bernstein JD, Skopicki HA, Aaronson KD (2005) Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487–1491
Yallop KG, Sheppard SV, Smith DC (2008) The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine. Anaesthesia 63:576–582
Smith MN, Best D, Sheppard SV et al (2008) The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction. Anaesthesia 63:701–704
Kaya K, Oguz M, Akar AR et al (2007) The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 31:290–297
Kramer BK, Preuner J, Ebenburger A et al (2002) Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 17:910–915
McBride WT, Allen S, Gormley SM et al (2004) Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine 27:81–89
Kulka PJ, Tryba M, Zenz M (1996) Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24:947–952
Parikh CR, Devarajan P (2008) New biomarkers of acute kidney injury. Crit Care Med 36:S159–S165
Kellum JA, Decker M (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531
Bellomo R, Chapman M, Finfer S et al (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143
Lauschke A, Teichgraber UK, Frei U et al (2006) Low-dose dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69:1669–1674
Tumlin JA, Finkel KW, Murray PT et al (2005) Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46:26–34
Brienza N, Malcangi V, Dalfino L et al (2006) A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34:707–714
Anderson RJ, Linas SI, Berns AS et al (1977) Nonoliguric acute renal failure. N Engl J Med 296:1134–1138
Bagshaw SM, Delaney A, Haase M et al (2007) Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 9:60–68
Kleinknecht D, Ganeval D, Gonzalez-Duque LA et al (1976) Furosemide in acute oliguric renal failure. A controlled trial. Nephron 17:51–58
Mehta RL, Pascual MT, Soroko S et al (2002) Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA 288:2547–2553
Hasselblad V, Gattis Stough W, Shah MR et al (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9:1064–1069
Karajala V, Mansour W, Kellum JA (2009) Diuretics in acute kidney injury. Minerva Anestesiol 75:251–257
Sirivella S, Gielchinsky I, Parsonnet V (2000) Mannitol, furosemide and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 69:501–506
Visweswaran P, Massin EK, Dubose TD Jr (1997) Mannitol-induced acute renal failure. J Am Soc Nephrol 8:1028–1033
Allgren RL, Marbury TC, Rahman SN et al (1997) Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:828–834
Lewis J, Salem MM, Chertow GM et al (2000) Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36:767–774
Sward K, Valsson F, Odencrants P et al (2004) Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 32:1310–1315
Beaver TM, Winterstein AG, Shuster JJ et al (2006) Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 29:18–24
Chow SL, Peng JT, Okamoto MP et al (2007) Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Ann Pharmacother 41:556–561
Witteles RM, Kao D, Christopherson D et al (2007) Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 50:1835–1840
Wiebe K, Meyer M, Wahlers T et al (1996) Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide). Eur J Med Res 1:259–265
Meyer M, Pfarr E, Schirmer G et al (1999) Therapeutic use of the natriuretic peptide ularitide in acute renal failure. Ren Fail 21:85–100
Hoffmann H, Markewitz A, Kreuzer E et al (1998) Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 9:235–240
Vesey DA, Cheung C, Pat B et al (2004) Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19:348–355
Gibney N, Hoste E, Burdmann EA et al (2008) Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol 3:876–880
Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 357:1316–1325
Palevsky PM (2008) Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med 36:S224–S228
Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212
Seabra VF, Balk EM, Liangos O et al (2008) Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 52:272–284
Durmaz I, Yagdi T, Calkavur T et al (2003) Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 75:859–864
Bouman CS, Oudemans-Van Straaten HM, Tijssen JG et al (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30:2205–2211
Demirkilic U, Kuralay E, Yenicesu M et al (2004) Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 19:17–20
Ronco C, Ricci Z (2008) Renal replacement therapies: physiological review. Intensive Care Med 34:2139–2146
Forni LG, Hilton PJ (1997) Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 336:1303–1309
Berbece AN, Richardson RM (2006) Sustained low-efficiency dialysis in the ICU: cost, anticoagulation and solute removal. Kidney Int 70:963–968
Kielstein JT, Hafer C (2006) Extended dialysis in intensive care: Korff dialysis rediscovered. Nephrologe 70:963–968
Rabindranath K, Adams J, Macleod AM et al (2007) Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev:CD003773
Bagshaw SM, Berthiaume LR, Delaney A et al (2008) Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 36:610–617
Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417–430
Paganini EP, Kanagasundaram NS, Larive B et al (2001) Prescription of adequate renal replacement in critically ill patients. Blood Purif 19:238–244
KDOQI (2006) Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S11–S145
Eloot S, Van Biesen W, Dhondt A et al (2008) Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73:765–770
Ronco C (2006) Recent evolution of renal replacement therapy in the critically ill patient. Crit Care 10:123
Conger JD (1975) A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 15:1056–1063
Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346:305–310
Ronco C, Bellomo R, Homel P et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30
Saudan P, Niederberger M, De Seigneux S et al (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70:1312–1317
Tolwani AJ, Campbell RC, Stofan BS et al (2008) Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19:1233–1238
Palevsky PM, Zhang JH, O’Connor TZ et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20
Faulhaber-Walter R, Hafer C, Jahr N et al (2009) The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 24:2179–2186
Kielstein JT (2009) Dosis der Nierenersatztherapie bei akutem Nierenversagen. Dtsch Med Wochenschr 134:1–3
Honore PM, Jamez J, Wauthier M et al (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581–3587
Vesconi S, Cruz DN, Fumagalli R et al (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13:R57
Chertow GM, Levy EM, Hammermeister KE et al (1998) Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104:343–348
Hamada Y, Kawachi K, Tsunooka N et al (2004) Capillary leakage in cardiac surgery with cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 12:193–197
Loeffelbein F, Zirell U, Benk C et al (2008) High colloid oncotic pressure priming of cardiopulmonary bypass in neonates and infants: implications on haemofiltration, weight gain and renal function. Eur J Cardiothorac Surg 34:648–652
Martin FL, Chen HH, Cataliotti A et al (2008) Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. Rev Cardiovasc Med 9:39–45
Interessenkonflikt
Verschiedene Autoren dieser Stellungnahme haben von Firmen, deren Produkte zur Diagnose, Prophylaxe und Therapie von Nierenfunktionsstörungen genutzt werden, Forschungsunterstützung, Vortrags- bzw. Beraterhonorare erhalten:
M. Heringlake (Forschungsförderung und Vortragshonorare durch: Gambro-Hospal, Edwards–Lifesciences, Roche-Diagnostics), D. Kindgen-Milles (Vortragshonorare und Forschungsförderung durch Fresenius Medical Care; Vortragshonorare von Bard, MSD und Pfizer), O. Vargas-Hein (Vortragshonorare durch Gambro-Hospal, Fresenius Medical Care, Forschungsförderung durch Roche Pharma und Sanofi Aventis), J. Kielstein (Forschungsunterstützung und Vortragshonorare durch Fresenius Medical Care).
Die Autoren N. Haake, F. Hackmann, M. Lance, H. Lufft, S. Just, A. Markewitz, A. Scherlitz, B. Trabold, D. Schmitt, U. Schirmer erklären, dass keine Interessenskonflikte bestehen.
Author information
Authors and Affiliations
Corresponding author
Additional information
Die Autoren M. Heringlake und D. Kindgen-Milles haben in gleichem Umfang an der Erstellung dieses Manuskripts mitgewirkt.
Rights and permissions
About this article
Cite this article
Heringlake, M., Kindgen-Milles, D., Hackmann, F. et al. Pathophysiologie, Prophylaxe und Therapie von Herzchirurgie-assoziierten Nierenfunktionsstörungen. Z Herz- Thorax- Gefäßchir 23, 349–373 (2009). https://doi.org/10.1007/s00398-009-0743-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00398-009-0743-8